Quince Therapeutics
PublicQuince Therapeutics is now publicly traded
The data on this page reflects Quince Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Private Placement
Jun 11, 2026
Total Funding Raised
$114.72M
Company Overview
Quince Therapeutics is a biotechnology company that acquires, develops, and commercializes therapeutics for debilitating and rare diseases.
AI Layer
Application
Keywords
reverse mergerpublic shell companycash shellrare disease therapeuticsorphan drugsclinical-stage biotechdrug developmentAI drug discoveryAtaxia-TelangiectasiaA-Tneurodegenerative diseasedrug repurposingdrug/device combination
Quince Therapeutics Comparables
Compare Quince Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Keystone Bio | 32% |
Quince Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Jun 11, 2026 |
Quince Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Private Placement |
| Balyasny Asset Management L.P. | Private Placement |
| LifeSci Venture Partners | Private Placement |
| Columbia Threadneedle Investments | Private Placement |
| Perceptive Advisors | Private Placement |
| Eventide Funds | Private Placement |
| Coastlands Capital LP | Private Placement |
Quince Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFirmographic Details
Headquarters—
Employee Range21
Year Founded2012
Last FundingJun 11, 2026
See something wrong or outdated?